Lost in Transition, Optimizing Sickle Cell Disease Care
As part of ongoing efforts to expand sickle cell disease knowledge and to reduce health inequities, DHH hosted its first Sickle Cell Health Hub Huddle with sickle cell disease experts.
How Can Female, LGBTQ, and BIPOC Clinical Trial Disparities Be Improved?
Female, BIPOC, and LGBTQ groups are under-represented in clinical trials. Learn where things stand with gender and other disparities in clinical trials and how to make improvements.
Maternal Health Disparities and Fostering Health Equity
Here’s a look at information about maternal health disparities, organizations that are working toward equitable maternal care for all pregnancies, and ways that others can help improve maternal health outcomes.
Breast Cancer in Men and Clinical Trial Disparities
Though some may not realize it, breast cancer can occur in men. Read about a study examining the exclusion of men from Phase III breast cancer clinical trials.
The Patient-Provider Relationship Role in Health Equity
In the pursuit of health equity, patient-provider relationships and patient perceptions about their health providers are vital in making improvements. Here’s a look at where we are and how to make progress.
Improving Health Equity for Diverse Populations in Clinical Trials
Clinical trials are a vital component of research for cancer treatments and other medical conditions. We connected with Dr. Leanne Woods-Burnham about a recent commentary on the role of diverse populations in U.S. clinical trials.
Ensuring Pneumococcal Immunity in Sickle Cell Disease Children
The genetic condition of sickle cell disease (SCD) results when sickle cell genes are inherited from each parent. We connected with Dr. Seethal Jacob about a study on maintaining an immune response against pneumococcal bacteria in children with SCD.
Health Disparities and Insurance Coverage, Where We Are and Moving Forward
When it comes to health insurance, not everyone has access to equitable healthcare in the U.S. Here’s a look at where we are and ways to make improvements in health insurance coverage and health disparities.
Late-Stage Diagnosis of Unscreened Cancer: A Health Disparity
During the COVID-19 pandemic there was a large drop in cancer screenings. This reduction could potentially decrease the chances of detecting many cancers at earlier stages and possibly lead to a greater amount of suffering from undiagnosed or late-stage diagnoses.
ADHD Diagnosis Disparities in Females and BIPOC Patients
ADHD goes as an undiagnosed and untreated struggle more often for girls, women, and certain Black, Indigenous, and People of Color (BIPOC) groups. Here's a look at ADHD and health disparities of female and BIPOC individuals.
What Do We Know About COVID-19 Vaccinations, the Delta Variant, and Onesimus?
Here’s a look at early U.S. immunization history, the significance of COVID-19 vaccinations, the Delta variant, and Onesimus.
What Is Monoclonal Gammopathy of Undetermined Significance (MGUS)?
After largely being an unknown risk previously, medical researchers examined MGUS and familial risk in a study. Here’s a look at what was learned from the study, other MGUS incidence information, and MGUS screening recommendations.
Can the Impact of Stress Lead to Disparities in Health Outcomes?
Study of the stress hormone cortisol is entering into research studies, and we at DHH find it a timely topic for its impacts to some BIPOC groups. Here’s a look at cortisol, the health impacts of cortisol, and ways to reduce cortisol levels.
High-Intensity Exercise and Renal Medullary Carcinoma in Those With Sickle Cell Trait
As the most commonly occurring blood disorder in the world, sickle cell trait primarily impacts those in the BIPOC community with African ancestry. We connected with Dr. Pavlos Msaouel about a study on high-intensity exercise in those with sickle cell trait.
A Guide for Physicians on Building Relationships With BIPOC Patients
Distrust in healthcare has been America’s hard pill to swallow especially for the BIPOC community. But how can members of healthcare, like physicians, regain the trust of their BIPOC patients?
Will Telemedicine Be a Mainstay for Myeloma Patients After the Pandemic?
Will telemedicine remain as a mainstay for myeloma patients after the pandemic? Learn the prime points from the Myeloma TelemEDucation Empowerment Resource Center.
Who Are Key Players in Your Breast Cancer Treatment?
When faced with the diagnosis of breast cancer for the first time, it can be overwhelming. Dr. Regina Hampton explains key players in the breast cancer treatment game.
Access Matters: Studying Disparities in Health Outcomes for Multiple Myeloma
New research from Heinz Ludwig, MD et al explores the global interrelations between Multiple Myeloma (MM) mortality and countries’ economic resources, patient empowerment, and health access and quality. The study is intended to inform about the associations between these factors, and to improve diagnosis, management, and outcome of patients globally.
Will Telemedicine Bridge Gaps to Equitable Care for Underserved Prostate Cancer Patients?
The Prostate Cancer TelemEDucation Resource Center helps improve prostate cancer patients’ and care partners’ familiarity with healthcare, and thus increase quality of care regardless of the COVID pandemic, geographical location, or racial disparities. The program focuses on the specific needs of Black men and other vulnerable communities to most effectively reduce healthcare disparities.
Is Breast Cancer Different for Black American Women?
Black American women have less breast cancer but die at higher rates than our white counterparts. Why is there a disparity?